InflaRx (IFRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.32, -8.33% vs the prior close of $1.44.
- Volume 1.54M shares, 2.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IFRX slides 8.3% to $1.32, a 6-month low on 2.1x normal volume. Closed at $1.32, -8.33% vs the prior close of $1.44. Day range $1.29–$1.47, opened at $1.47.
IFRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IFRX slides 8.3% to $1.32, a 6-month low on 2.1x normal volume
- Closed at $1.32, -8.33% vs the prior close of $1.44. Day range $1.29–$1.47, opened at $1.47.
- Volume was 1.54M shares, 2.1x its 50-day average of 731.18K — unusually heavy trading.
- Price is -32.5% vs its 50-day average ($1.95) and -18.1% vs its 200-day average ($1.61).
- 52-week range $0.80–$2.95; today's close sits at 24% of that range, 55.2% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — IFRX dips 2.7% to $1.44, a 3-month low, 4 down days in a row
- Closed at $1.44, -2.70% vs the prior close of $1.48. Day range $1.43–$1.53, opened at $1.47.
- Volume was 551.50K shares, 0.8x its 50-day average of 734.35K.
- Price is -26.6% vs its 50-day average ($1.96) and -10.5% vs its 200-day average ($1.61).
- 52-week range $0.80–$2.95; today's close sits at 30% of that range, 51.2% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — IFRX slides 4.5% to $1.48, a 3-month low, 3 down days in a row
- Closed at $1.48, -4.52% vs the prior close of $1.55. Day range $1.46–$1.54, opened at $1.53.
- Volume was 585.60K shares, 0.8x its 50-day average of 740.41K.
- Price is -24.9% vs its 50-day average ($1.97) and -7.9% vs its 200-day average ($1.61).
- 52-week range $0.80–$2.95; today's close sits at 32% of that range, 49.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IFRX dips 2.5% to $1.55
- Closed at $1.55, -2.52% vs the prior close of $1.59. Day range $1.54–$1.61, opened at $1.59.
- Volume was 367.10K shares, 0.5x its 50-day average of 744.23K — lighter than usual.
- Price is -21.5% vs its 50-day average ($1.98) and -3.5% vs its 200-day average ($1.61).
- 52-week range $0.80–$2.95; today's close sits at 35% of that range, 47.4% below the 52-week high.
Oct 12, 2026 — IFRX dips 0.6% to $1.59
- Closed at $1.59, -0.62% vs the prior close of $1.60. Day range $1.54–$1.64, opened at $1.60.
- Volume was 467.80K shares, 0.6x its 50-day average of 746.55K.
- Price is -19.7% vs its 50-day average ($1.98) and -0.8% vs its 200-day average ($1.60).
- 52-week range $0.80–$2.95; today's close sits at 37% of that range, 46.1% below the 52-week high.
Oct 9, 2026 — IFRX jumps 4.6% to $1.60
- Closed at $1.60, +4.58% vs the prior close of $1.53. Day range $1.55–$1.70, opened at $1.55.
- Volume was 740.70K shares, 1.0x its 50-day average of 754.01K.
- Price is -19.3% vs its 50-day average ($1.98) and -0.1% vs its 200-day average ($1.60).
- 52-week range $0.80–$2.95; today's close sits at 37% of that range, 45.7% below the 52-week high.
Oct 8, 2026 — IFRX dips 1.9% to $1.53, a 3-month low, 4 down days in a row
- Closed at $1.53, -1.92% vs the prior close of $1.56. Day range $1.47–$1.60, opened at $1.55.
- Volume was 1.14M shares, 1.5x its 50-day average of 749.31K.
- Price is -22.9% vs its 50-day average ($1.98) and -4.3% vs its 200-day average ($1.60).
- 52-week range $0.80–$2.95; today's close sits at 34% of that range, 48.1% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — IFRX dips 1.3% to $1.56, a 3-month low, 3 down days in a row
- Closed at $1.56, -1.27% vs the prior close of $1.58. Day range $1.55–$1.60, opened at $1.60.
- Volume was 459.30K shares, 0.6x its 50-day average of 764.15K.
- Price is -21.5% vs its 50-day average ($1.99) and -2.3% vs its 200-day average ($1.60).
- 52-week range $0.80–$2.95; today's close sits at 35% of that range, 47.1% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — IFRX slides 6.0% to $1.58, a 3-month low
- Closed at $1.58, -5.95% vs the prior close of $1.68. Day range $1.57–$1.78, opened at $1.69.
- Volume was 720.60K shares, 0.9x its 50-day average of 768.31K.
- Price is -20.6% vs its 50-day average ($1.99) and -0.9% vs its 200-day average ($1.59).
- 52-week range $0.80–$2.95; today's close sits at 36% of that range, 46.4% below the 52-week high.
Oct 5, 2026 — IFRX dips 2.3% to $1.68, a 1-month low
- Closed at $1.68, -2.33% vs the prior close of $1.72. Day range $1.65–$1.72, opened at $1.70.
- Volume was 701.00K shares, 0.9x its 50-day average of 770.75K.
- Price is -15.6% vs its 50-day average ($1.99) and +5.6% vs its 200-day average ($1.59).
- 52-week range $0.80–$2.95; today's close sits at 41% of that range, 43.0% below the 52-week high.
Oct 2, 2026 — IFRX rises 0.6% to $1.72
- Closed at $1.72, +0.58% vs the prior close of $1.71. Day range $1.72–$1.80, opened at $1.74.
- Volume was 422.10K shares, 0.5x its 50-day average of 773.30K — lighter than usual.
- Price is -13.7% vs its 50-day average ($1.99) and +8.3% vs its 200-day average ($1.59).
- 52-week range $0.80–$2.95; today's close sits at 43% of that range, 41.7% below the 52-week high.
IFRX latest news & SEC filings
Every SEC filing by or about IFRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 6, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade IFRX
- How much it moves: over the last 20 sessions the average daily move was 3.05% (largest 8.3%). That is a volatile stock.
- Liquidity: about 572.53K shares (≈$755.74K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.32 vs a range of $0.80–$2.95 (24% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Aug 6, 2026; 6-K Jun 30, 2026; 6-K May 7, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IFRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.47 | 1.47 | 1.29 | 1.32 | 1.54M |
| Oct 15, 2026 | 1.47 | 1.53 | 1.43 | 1.44 | 551.50K |
| Oct 14, 2026 | 1.53 | 1.54 | 1.46 | 1.48 | 585.60K |
| Oct 13, 2026 | 1.59 | 1.61 | 1.54 | 1.55 | 367.10K |
| Oct 12, 2026 | 1.60 | 1.64 | 1.54 | 1.59 | 467.80K |
| Oct 9, 2026 | 1.55 | 1.70 | 1.55 | 1.60 | 740.70K |
| Oct 8, 2026 | 1.55 | 1.60 | 1.47 | 1.53 | 1.14M |
| Oct 7, 2026 | 1.60 | 1.60 | 1.55 | 1.56 | 459.30K |
| Oct 6, 2026 | 1.69 | 1.78 | 1.57 | 1.58 | 720.60K |
| Oct 5, 2026 | 1.70 | 1.72 | 1.65 | 1.68 | 701.00K |
| Oct 2, 2026 | 1.74 | 1.80 | 1.72 | 1.72 | 422.10K |
| Oct 1, 2026 | 1.83 | 1.86 | 1.71 | 1.71 | 369.80K |
| Sep 30, 2026 | 1.87 | 1.89 | 1.80 | 1.80 | 302.40K |
| Sep 29, 2026 | 1.83 | 1.89 | 1.80 | 1.85 | 268.30K |
| Sep 28, 2026 | 1.88 | 1.95 | 1.80 | 1.82 | 426.40K |
| Sep 25, 2026 | 1.94 | 2.04 | 1.87 | 1.89 | 399.90K |
| Sep 24, 2026 | 1.97 | 2.02 | 1.89 | 1.93 | 510.00K |
| Sep 23, 2026 | 2.08 | 2.09 | 1.96 | 1.96 | 564.80K |
| Sep 22, 2026 | 2.12 | 2.19 | 2.04 | 2.08 | 571.20K |
| Sep 21, 2026 | 2.11 | 2.19 | 2.07 | 2.12 | 345.10K |
About InflaRx
InflaRx (IFRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in JENA, Germany. State of incorporation: Netherlands. Fiscal year ends December 31. SEC CIK 1708688.
IFRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Richard Brudnick | Director | Mar 18, 2026 |
| Nicolas Fulpius | Director | Mar 18, 2026 |
| Anthony S Gibney | Director | Mar 18, 2026 |
| Renfeng Guo | Chief Scientific Officer | Mar 18, 2026 |
| Hege Hellstrom | Director | Mar 18, 2026 |
| Mark Kubler | Director | Mar 18, 2026 |
| Niels Riedemann | Chief Executive Officer | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Renfeng Guo | Chief Scientific Officer | Mar 18, 2026 |
| Derval Ocarroll | See Remarks | Mar 18, 2026 |
| Niels Riedemann | Chief Executive Officer | Mar 18, 2026 |
| Thomas Taapken | Chief Financial Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
IFRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
IFRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IFRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.